Grace Therapeutics, Inc. ($GRCE)
Filing Information
| Accession Number | 0001493152-26-045809 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 5, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
60,490
Total Value
$123,819.14
P&L
+0.6% (+$790.26)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock, par value $0.0001 per share | โ | Oct 1, 2026 | Purchase | 38,796 | $2.04 | $78,961.50 | 2,836,963 | Indirect | By Opaleye, L.P. | View Details | |
10% Owner | Common Stock, par value $0.0001 per share | โ | Oct 2, 2026 | Purchase | 20,000 | $2.07 | $41,368.00 | 2,856,963 | Indirect | By Opaleye, L.P. | View Details | |
10% Owner | Common Stock, par value $0.0001 per share | โ | Oct 5, 2026 | Purchase | 1,694 | $2.06 | $3,489.64 | 2,858,657 | Indirect | By Opaleye, L.P. | View Details |